PharmaSynth Formulations Limited, a progressive pharmaceutical company celebrated its 40th Foundation Day across India. The aim of the company is to make available high-quality medicines at affordable prices to the general public with great service. PharmaSynth Company has been honored with many national and international awards.
Records revenue growth of 22% to INR 762 crores in Q4 FY23 & grew 30% to INR 3149 crores in FY23 & operating EBITDA increased by 21% to INR 181 crores in Q4 FY23 A year of market-beating growth, superior performance & an optimistic outlook towards
87% of respondents deemed mRNA a key modality for the future More than 60% vaccine makers surveyed plan revamp or new facilities for mRNA manufacturing to meet demand Skilled personnel, tech-transfer expertise, reliable supply chain, and regulatory guidelines critical to new technology adoption According
AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the
India Pharma & India Medical Device 2023 aims to position India as a leading international healthcare hub and attract investments. The Union Minister of Health & Family Welfare and Chemicals & Fertilizers, Dr Mansukh Mandaviya today said, “There is a need to harness India's vast potential in the
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans Venus Remedies Limited, a leading research-based pharmaceutical company, has achieved another significant milestone by securing a Good Manufacturing Practices (GMP) certification from
In sync with the World Asthma Day 2023 theme – ‘Asthma Care for All’, the campaign aims to raise awareness among physicians & Asthma patients Amid World Asthma Day-2023, a leading pharmaceutical company – Alkem Laboratories has announced the launch of its awareness campaign #RelieverFreeIndia to raise
Launches its new range of 25 allopathy ophthalmic products GUERISON, a global pharmaceutical player with a focus on ophthalmology business has finally set up its footprints in India’s ophthalmology market (north, east and west region of India) with the launch of its new range of 25
Mankind Pharma Ltd on Monday announced that it has invested in a clinical stage specialty pharmaceutical company, Actimed Therapeutics Ltd, UK. Actimed Therapeutics is focused on bringing innovation to the treatment of cancer cachexia, an unmet medical need for cancer patients, and other muscle wasting
Global pharma major Lupin Limited (Lupin) today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Drospirenone Tablets, 4 mg, to market a generic equivalent of Slynd® Tablets, 4 mg, of Exeltis USA Inc. Drospirenone
